MARKET WIRE NEWS
  1. Home
  2. Stock
  3. TRAW
  4. News
TRAW
Quote
Short
News
Articles
Message Board

Traws Pharma Inc. (NASDAQ : TRAW ) News

Traws Pharma Inc. (NASDAQ: TRAW) News Releases

TRAW News Releases
TRAW : NASDAQ
GlobeNewswire
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
TRAW : NASDAQ
PR Newswire
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
TRAW : NASDAQ
PR Newswire
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
TRAW : NASDAQ
GlobeNewswire
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
TRAW : NASDAQ
GlobeNewswire
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
TRAW : NASDAQ
SeekingAlpha
Annovis Bio appoints CFO
TRAW : NASDAQ
GlobeNewswire
Annovis Appoints Mark Guerin as Chief Financial Officer
TRAW : NASDAQ
SeekingAlpha
Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call Transcript
TRAW : NASDAQ
SeekingAlpha
Traws Pharma GAAP EPS of -$0.11, revenue of $2.73M
TRAW : NASDAQ
US Earnings Reports
Expected US Company Earnings on Thursday, August 14th, 2025
Back to StartNext 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.